Literature DB >> 2245877

Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition. Possible link between hyperinsulinemia and atherosclerosis.

H A Barakat1, J W Carpenter, V D McLendon, P Khazanie, N Leggett, J Heath, R Marks.   

Abstract

The possible causes of the enhanced risk for coronary heart disease (CHD) were examined in morbidly obese women with normoglycemia, impaired glucose tolerance (IGT), and non-insulin-dependent diabetes mellitus (NIDDM) before and after gastric bypass surgery. Compared with age-matched lean women, plasma lipid and apolipoprotein concentrations of the obese women before surgery favored atherogenesis. The risk for CHD may further be exacerbated in the IGT and NIDDM groups by the prevalence of smaller and denser low-density-lipoprotein (LDL) particles. LDL size correlated negatively with plasma insulin levels independent of triglyceride levels, age, or body mass index (BMI). After surgery, BMI, plasma insulin, and triglyceride levels decreased, but LDL size increased, and LDL density decreased. Neither cholesterol nor LDL cholesterol levels were affected after surgery, but high-density-lipoprotein cholesterol was increased in all patients after surgery. Although the mechanisms underlying the changes in the properties of LDL could not be determined from this study, these changes appear to be of benefit in reducing CHD risk in these patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2245877     DOI: 10.2337/diab.39.12.1527

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  22 in total

Review 1.  Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.

Authors:  Christian K Roberts; Andrea L Hevener; R James Barnard
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

2.  Multilocus genetic determinants of LDL particle size in coronary artery disease families.

Authors:  J I Rotter; X Bu; R M Cantor; C H Warden; J Brown; R J Gray; P J Blanche; R M Krauss; A J Lusis
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

3.  Serum lipid, lipoprotein and apolipoprotein changes in gestational diabetes mellitus: a cross-sectional and prospective study.

Authors:  E Koukkou; G F Watts; C Lowy
Journal:  J Clin Pathol       Date:  1996-08       Impact factor: 3.411

4.  Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides.

Authors:  S Lahdenperä; M Syvänne; J Kahri; M R Taskinen
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

5.  Relationship between C peptide and chronic complications in type-2 diabetes mellitus.

Authors:  Ramazan Sari; Mustafa Kemal Balci
Journal:  J Natl Med Assoc       Date:  2005-08       Impact factor: 1.798

Review 6.  Exercise and diet in the prevention and control of the metabolic syndrome.

Authors:  R J Barnard; S J Wen
Journal:  Sports Med       Date:  1994-10       Impact factor: 11.136

7.  Methylation at CPT1A locus is associated with lipoprotein subfraction profiles.

Authors:  Alexis C Frazier-Wood; Stella Aslibekyan; Devin M Absher; Paul N Hopkins; Jin Sha; Michael Y Tsai; Hemant K Tiwari; Lindsay L Waite; Degui Zhi; Donna K Arnett
Journal:  J Lipid Res       Date:  2014-04-07       Impact factor: 5.922

8.  Effects of exercise cessation on lipids and lipoproteins in distance runners and power athletes.

Authors:  T Hortobágyi; J A Houmard; R G Israel; J W Carpenter; J Heath; H A Barakat
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1993

9.  A preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non-diabetic subjects.

Authors:  S M Haffner; L Mykkänen; D Robbins; R Valdez; H Miettinen; B V Howard; M P Stern; R Bowsher
Journal:  Diabetologia       Date:  1995-11       Impact factor: 10.122

10.  Improvement of lipid profile in type 2 (non-insulin-dependent) diabetes mellitus by insulin-like growth factor I.

Authors:  P D Zenobi; P Holzmann; Y Glatz; W F Riesen; E R Froesch
Journal:  Diabetologia       Date:  1993-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.